Advocacy & Science Policy Committee
The Advocacy and Science Policy Committee is charged with generating recommendations in response to proposed government research initiatives, regulatory requirements, NIH research grant submission policies; and reviewing issues that affect basic and clinical researchers who are members of ASBMR.
This committee is also charged to:
- Work in close collaboration with FASEB and other coalitions to track the effect of science policies that most impact members.
- Collaborate with the National Bone Health Alliance (NBHA) and FASEB to provide expert testimony and educational material to aid efforts on Capitol Hill and suggest scientific directions for new grants and funding mechanisms to federal research funding institutions.
- Review and communicate advocacy- and science policy-related information regularly to the membership.
- Working closely with other committees when necessary on issues of mutual concern and of importance to ASBMR members.
Deborah Veis, M.D., Ph.D., Chairperson
Robert Blank, M.D., Ph.D.
Amel Dudakovic, Ph.D.
Maureen Devlin, Ph.D.
Michael Hadjiargyrou, Ph.D.
Louis Gerstenfeld, Ph.D.
Lisa Langsetmo, Ph.D., MS
Elsa Strotmeyer, Ph.D., MPH
Deneen Wellik, Ph.D.
Deborah Wenkert, M.D.
Marc Wein, M.D., Ph.D.
Kurt Hankenson, D.V.M., Ph.D., Council Liaison
Ann Elderkin, P.A., Staff Liaison
Douglas Fesler, Staff Liaison
Lauren Strup, Staff Liaison